275 related articles for article (PubMed ID: 29282992)
1. Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugate.
Ma P; Sun Y; Chen J; Li H; Zhu H; Gao X; Bi X; Zhang Y
Drug Deliv; 2018 Nov; 25(1):153-165. PubMed ID: 29282992
[TBL] [Abstract][Full Text] [Related]
2. Overcoming Multidrug Resistance through the GLUT1-Mediated and Enzyme-Triggered Mitochondrial Targeting Conjugate with Redox-Sensitive Paclitaxel Release.
Ma P; Chen J; Bi X; Li Z; Gao X; Li H; Zhu H; Huang Y; Qi J; Zhang Y
ACS Appl Mater Interfaces; 2018 Apr; 10(15):12351-12363. PubMed ID: 29569435
[TBL] [Abstract][Full Text] [Related]
3. Sugar Modification Enhances Cytotoxic Activity of PAMAM-Doxorubicin Conjugate in Glucose-Deprived MCF-7 Cells - Possible Role of GLUT1 Transporter.
Sztandera K; Działak P; Marcinkowska M; Stańczyk M; Gorzkiewicz M; Janaszewska A; Klajnert-Maculewicz B
Pharm Res; 2019 Jul; 36(10):140. PubMed ID: 31367876
[TBL] [Abstract][Full Text] [Related]
4. Cell microenvironment-controlled antitumor drug releasing-nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy.
Guo Y; Zhang Y; Li J; Zhang Y; Lu Y; Jiang X; He X; Ma H; An S; Jiang C
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5444-53. PubMed ID: 25686400
[TBL] [Abstract][Full Text] [Related]
5. Rational Design of a New Self-Codelivery System from Redox-Sensitive Camptothecin-Cytarabine Conjugate Assembly for Effectively Synergistic Anticancer Therapy.
He W; Hu X; Jiang W; Liu R; Zhang D; Zhang J; Li Z; Luan Y
Adv Healthc Mater; 2017 Dec; 6(24):. PubMed ID: 29076266
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
[TBL] [Abstract][Full Text] [Related]
7. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
[TBL] [Abstract][Full Text] [Related]
8. PAMAM-camptothecin conjugate inhibits proliferation and induces nuclear fragmentation in colorectal carcinoma cells.
Thiagarajan G; Ray A; Malugin A; Ghandehari H
Pharm Res; 2010 Nov; 27(11):2307-16. PubMed ID: 20552256
[TBL] [Abstract][Full Text] [Related]
9. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
10. Dynamic core crosslinked camptothecin prodrug micelles with reduction sensitivity and boronic acid-mediated enhanced endocytosis: An intelligent tumor-targeted delivery nanoplatform.
Huang Y; Zhang W; Xu Y; Zhu S; Wu Y; Chen T; Xiao Y; Lu W; Zhang X; Yu J
Int J Pharm; 2020 Apr; 580():119250. PubMed ID: 32209369
[TBL] [Abstract][Full Text] [Related]
11. Increased Active Tumor Targeting by An αvβ3-Targeting and Cell-Penetrating Bifunctional Peptide-Mediated Dendrimer-Based Conjugate.
Ma P; Yu H; Zhang X; Mu H; Chu Y; Ni L; Xing P; Wang Y; Sun K
Pharm Res; 2017 Jan; 34(1):121-135. PubMed ID: 27848167
[TBL] [Abstract][Full Text] [Related]
12. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting.
Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z
Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739
[TBL] [Abstract][Full Text] [Related]
13. Tunable conjugation densities of camptothecin on hyaluronic acid for tumor targeting and reduction-triggered release.
Chen Z; He N; Chen M; Zhao L; Li X
Acta Biomater; 2016 Oct; 43():195-207. PubMed ID: 27424081
[TBL] [Abstract][Full Text] [Related]
14. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
[TBL] [Abstract][Full Text] [Related]
15. Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA.
Chen F; Zhang J; He Y; Fang X; Wang Y; Chen M
Biomater Sci; 2016 Jan; 4(1):167-82. PubMed ID: 26484363
[TBL] [Abstract][Full Text] [Related]
16. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F
Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584
[TBL] [Abstract][Full Text] [Related]
17. High Drug Loading, Reversible Disulfide Core-Cross-Linked Multifunctional Micelles for Triggered Release of Camptothecin.
Ling L; Ismail M; Du Y; Xia Q; He W; Yao C; Li X
Mol Pharm; 2018 Dec; 15(12):5479-5492. PubMed ID: 30376635
[TBL] [Abstract][Full Text] [Related]
18. Drug pH-sensitive release in vitro and targeting ability of polyamidoamine dendrimer complexes for tumor cells.
Liu D; Hu H; Zhang J; Zhao X; Tang X; Chen D
Chem Pharm Bull (Tokyo); 2011; 59(1):63-71. PubMed ID: 21212549
[TBL] [Abstract][Full Text] [Related]
19. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22.
Yang A; Liu Z; Yan B; Zhou M; Xiong X
Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540
[TBL] [Abstract][Full Text] [Related]
20. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
